GSK3B and supranuclear palsy, progressive, 1: Tideglusib, a novel small-molecule GSK-3β inhibitor, did not demonstrate evidence of efficacy in mild to moderate AD (ARGO, NCT01350362) or in PSP (TAUROS, NCT01049399) (104, 105).